Nutritional support in multimodal therapy for cancer cachexia.

Area of Science:

• Oncology
• Metabolism
• Nutrition Science

Background:

• Cancer cachexia is characterized by progressive weight loss, muscle atrophy, and metabolic dysregulation.
• It results from a complex interplay of reduced food intake, increased energy expenditure, and systemic inflammation.
• This condition significantly impacts patient outcomes and quality of life.

Purpose of the Study:

• To review the pathophysiology of cancer cachexia, focusing on metabolic alterations and nutritional challenges.
• To discuss current and emerging therapeutic strategies for managing cancer cachexia.
• To emphasize the importance of a multimodal and early intervention approach.

Main Methods:

• Literature review of studies on cancer cachexia pathophysiology and treatment.
• Analysis of the role of hypermetabolism, inflammation, and anorexia in disease progression.
• Evaluation of nutritional support and pharmacological interventions.

Main Results:

• Cancer cachexia involves a catabolic state with increased resting energy expenditure and reduced nutrient intake.
• Nutritional support alone has limited efficacy without addressing the underlying catabolic metabolism.
• Pharmacological interventions can target anorexia, inflammation, and muscle catabolism.

Conclusions:

• Effective management of cancer cachexia requires a multidisciplinary approach addressing both metabolic derangements and nutritional deficits.
• Early intervention is crucial for better outcomes, with oral nutritional supplementation preferred over parenteral nutrition.
• While complete reversal may not always be possible, stabilizing cachexia can improve survival, function, and quality of life.